Copyright 2012 Medical News TodayLatest Health News and Medical News posted throughout the day, every day.http://www.medicalnewstoday.com/sections/gout/admin@medicalnewstoday.com (MNT Admin)editors@medicalnewstoday.com (MNT Editors)en-us Mon, 09 Jan 2012 00:00:00 PSThttp://www.medicalnewstoday.com/releases/240014.phphttp://www.medicalnewstoday.com/releases/240014.php A phase II clinical trial found that rilonacept, an inhibitor of the protein interleukin-1 (IL-1), significantly reduced acute gout flares that occur when initiating uric acid-lowering therapy...Gout Fri, 06 Jan 2012 10:00:00 PSThttp://www.medicalnewstoday.com/articles/240029.phphttp://www.medicalnewstoday.com/articles/240029.phpAccording to a phase II clinical trial, the drug rilonacept, which inhibits the protein interleukin-1 (IL-1), substantially reduces acute gout flares that occur at the start of uric acid-reducing therapy and is noted to be generally well tolerated with no serious infections or serious adverse events occurring in relation to the treatment...Gout Sat, 26 Nov 2011 01:00:00 PSThttp://www.medicalnewstoday.com/releases/238276.phphttp://www.medicalnewstoday.com/releases/238276.phpRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's supplemental Biologics License Application (sBLA) for ARCALYST Injection for Subcutaneous Use for the prevention of gout flares in patients initiating uric acid-lowering therapy...Gout Wed, 09 Nov 2011 05:00:00 PSThttp://www.medicalnewstoday.com/articles/237371.phphttp://www.medicalnewstoday.com/articles/237371.phpResults from a new pharmacokinetic (PK) study presented at the annual meeting of the American College of Rheumatology (ACR) provide new evidence-based guidance for healthcare providers on using colchicine for gout flare prophylaxis in the presence of renal impairment...Gout Mon, 07 Nov 2011 01:00:00 PSThttp://www.medicalnewstoday.com/releases/237207.phphttp://www.medicalnewstoday.com/releases/237207.phpX-ray images known as CT scans can help confirm gout in patients who are suspected of having the painful condition but receive negative results from traditional tests, a Mayo Clinic study has found. The type of CT scan analyzed, dual-energy computed tomography, is also valuable for diagnosing people who cannot be tested with the typical method of drawing fluid from joints, researchers found...Gout Mon, 07 Nov 2011 00:00:00 PSThttp://www.medicalnewstoday.com/releases/237194.phphttp://www.medicalnewstoday.com/releases/237194.phpExperts from NYU Langone Medical Center will present new research findings and clinical insight into the treatment of rheumatic and bone diseases in a variety of presentations at the American College of Rheumatology (ACR) 2011 Annual Scientific Meeting in Chicago, November 5-9, 2011...Arthritis / Rheumatology Tue, 04 Oct 2011 00:00:00 PSThttp://www.medicalnewstoday.com/releases/235367.phphttp://www.medicalnewstoday.com/releases/235367.phpNew research shows that use of poor footwear is common among patients with gout. According to the study published in Arthritis Care & Research, a peer-reviewed journal of the American College of Rheumatology (ACR), gout patients who make poor footwear choices experienced higher foot-related pain, impairment and disability...Gout Wed, 17 Aug 2011 09:00:00 PSThttp://www.medicalnewstoday.com/articles/232907.phphttp://www.medicalnewstoday.com/articles/232907.phpAccording to a study in the August 17 issue of JAMA, patients with severe, chronic gout who took pegloticase for 6 months as an alternative to conventional gout treatment that some patients may not respond to, showed greater improvements of uric acid levels as well as physical function and quality of life...Gout Wed, 17 Aug 2011 01:00:00 PSThttp://www.medicalnewstoday.com/releases/232854.phphttp://www.medicalnewstoday.com/releases/232854.phpInjections of pegloticase, a modified porcine enzyme, can produce significant and sustained clinical improvements in 2 out of 5 patients with chronic gout that is resistant to conventional therapies, researchers report in the August 17, 2011, issue of JAMA...Gout Tue, 16 Aug 2011 15:00:00 PSThttp://www.medicalnewstoday.com/articles/232842.phphttp://www.medicalnewstoday.com/articles/232842.phpIndividuals with severe, chronic gout who have not responded to conventional treatment may benefit from six-months' worth of pegloticase treatment. Researchers from Duke University Medical Center, Durham, N.C., reported in JAMA (Journal of the American Medical Association) that individuals experienced better levels of uric acid as well as physical function, quality of life, and less pain...Gout Fri, 29 Jul 2011 01:00:00 PSThttp://www.medicalnewstoday.com/releases/231942.phphttp://www.medicalnewstoday.com/releases/231942.phpA new study shows the prevalence of gout in the U.S. has risen over the last twenty years and now affects 8.3 million (4%) Americans. Prevalence of increased uric acid levels (hyperuricemia) also rose, affecting 43.3 million (21%) adults in the U.S...Gout Thu, 28 Jul 2011 12:00:00 PSThttp://www.medicalnewstoday.com/articles/231909.phphttp://www.medicalnewstoday.com/articles/231909.phpEight million Americans, almost 6% of men and 2% of women have got the gout, a painful affliction in which uric acid crystals are deposited in the joints. In a self reported survey, the prevalence of gout continues to climb along with rates of related conditions such as hypertension and metabolic syndrome, reaching 3.9% in 2008, according to a new study released this week...Gout Sat, 04 Jun 2011 19:00:00 PSThttp://www.medicalnewstoday.com/releases/227425.phphttp://www.medicalnewstoday.com/releases/227425.phpHealth professionals should ensure they are prescribing correct doses of colchicine, a treatment for acute gout, after three elderly patients were hospitalised within a fortnight, doctors at St Vincent's Hospital in Sydney say in a letter published in the Medical Journal of Australia...Gout Fri, 27 May 2011 09:00:00 PSThttp://www.medicalnewstoday.com/releases/226781.phphttp://www.medicalnewstoday.com/releases/226781.phpBioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today presented positive data from its two completed, randomized, double-blind, placebo-controlled Phase 2 studies of BCX4208 in patients with gout at the Annual European Congress of Rheumatology hosted by the European League Against Rheumatism (EULAR) in London, U.K...Gout Fri, 27 May 2011 02:00:00 PSThttp://www.medicalnewstoday.com/releases/226701.phphttp://www.medicalnewstoday.com/releases/226701.phpA pan-European study of 755 gout patients found that prevalence of self-reported gout was highest in the UK (2.2%) and lowest in France (0.76%)...Gout Thu, 26 May 2011 08:00:00 PSThttp://www.medicalnewstoday.com/releases/226623.phphttp://www.medicalnewstoday.com/releases/226623.phpArdea Biosciences, Inc. (Nasdaq: RDEA) announced today that additional positive clinical and preclinical results from its development program of lesinurad, the Company's lead product candidate for the treatment of hyperuricemia and gout, were presented at the Annual European Congress of Rheumatology hosted by the European League Against Rheumatism (EULAR) in London, UK...Gout Wed, 25 May 2011 11:00:00 PSThttp://www.medicalnewstoday.com/articles/226482.phphttp://www.medicalnewstoday.com/articles/226482.phpNovartis is happy with results of new testing that supports approval of gout, or gouty arthritis treatment which is already in the review pipeline according to a new release this week by the Swiss/New York pharmaceutical giant. It is proving very successful in reducing patients' pain and limiting the risk of new attacks...Gout Thu, 19 May 2011 08:00:00 PSThttp://www.medicalnewstoday.com/releases/225919.phphttp://www.medicalnewstoday.com/releases/225919.phpA new survey from the nonprofit Gout & Uric Acid Education Society (GUAES) highlights an alarming awareness gap among Americans regarding the risk factors for gout, a chronic, potentially disabling form of arthritis which now affects an estimated 8.3 million Americans¹...Gout Mon, 18 Apr 2011 03:00:00 PSThttp://www.medicalnewstoday.com/releases/222678.phphttp://www.medicalnewstoday.com/releases/222678.phpTeijin Pharma Limited, the core company of the Teijin Group's medical and pharmaceutical business, announced today that it has recently signed exclusive distributorship agreements with licensees in Turkey, Mexico and the Caribbean and Middle East and North African (MENA) regions for the expanded global marketing of TMX-67 (febuxostat), a novel drug developed by Teijin Pharma fo...Gout Fri, 25 Feb 2011 02:00:00 PSThttp://www.medicalnewstoday.com/releases/217437.phphttp://www.medicalnewstoday.com/releases/217437.phpAs part of the 60 Plus Association's "Keeping Seniors Safe" project, the organization's chairman, Jim Martin, recently sent letters to the CEOs of five Part-D Medicare plans, urging them to provide accessible colchicine-based medications to gout patients after untested and potentially harmful options were removed from the marketplace as part of an important Food and Drug Admini...Medicare / Medicaid / SCHIP Mon, 24 Jan 2011 00:00:00 PSThttp://www.medicalnewstoday.com/releases/214469.phphttp://www.medicalnewstoday.com/releases/214469.phpTeijin Pharma Limited, the core company of the Teijin Group's medical and pharmaceutical business, announced today that Japan's Ministry of Health, Labour and Welfare approved TMX-67 (febuxostat), Teijin Pharma's novel drug for treating hyperuricemia, on January 21...Urology / Nephrology Wed, 19 Jan 2011 01:00:00 PSThttp://www.medicalnewstoday.com/releases/214021.phphttp://www.medicalnewstoday.com/releases/214021.phpThe amount of uric acid in one's joints may increase the likelihood of severe osteoarthritis, the most common form of arthritis worldwide, according to researchers at Duke University Medical Center. Osteoarthritis is a debilitating joint degeneration for which no drug has been proven to slow or halt its progression...Arthritis / Rheumatology Fri, 10 Dec 2010 06:00:00 PSThttp://www.medicalnewstoday.com/releases/211013.phphttp://www.medicalnewstoday.com/releases/211013.phpDecision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that by 2019 the acute gout drug market will triple in size to $117 million and the chronic gout drug market will reach $1.83 billion...Gout Thu, 09 Dec 2010 05:00:00 PSThttp://www.medicalnewstoday.com/releases/210813.phphttp://www.medicalnewstoday.com/releases/210813.phpBioTrends Research Group, Inc. finds that although Allopurinol remains the gold standard uric acid lowering (UAL) therapy for gout in the European Union (EU), Teijin Pharma/Ipsen/Menarini's Adenuric (currently available in France, Germany and the United Kingdom) has already achieved significant market penetration...Gout Wed, 24 Nov 2010 03:00:00 PSThttp://www.medicalnewstoday.com/releases/209133.phphttp://www.medicalnewstoday.com/releases/209133.phpBioTrends Research Group, Inc. is pleased to announce the recent publication of a syndicated report, TreatmentTrends®: Gout. This biannual report provides a comprehensive market overview of current and future treatment trends in gout based on a primary research study fielded among 60 primary care physicians (PCPs) and 123 rheumatologists in the U.S...Gout